-transparent.png){kind=logo}
Astressin, a novel corticotropin releasing factor (CRF) antagonist, has been found to be particularly potent at inhibiting the hypothalamo-pituitary-adrenal axis. The aim of the present study was to determine the effects in rats of astressin in attenuating the anxiogenic-like response produced by social stress and intracerebroventricular (ICV) CRF administration on the elevated plus-maze, and ICV CRF-induced locomotor activation in the rat. Astressin significantly reversed the anxiogenic-like response induced by both social stress and ICV rat/humanCRF (r/hCRF) on the elevated plus-maze, but failed to block the effects of r/hCRF-induced locomotor activity in a familiar environment. When these results were compared to previous studies performed with the same paradigms using other CRF antagonists, astressin showed effects similar to those of D-PheCRF(12-41) on plus-maze performance. However, contrary to alpha-helicalCRF(9-41) and D-PheCRF(12-41), astressin had no effect on CRF-induced locomotor activity. These results suggest that astressin may have a unique anti-CRF profile compared to previously tested antagonists.
M G Spina, and
A M Basso, and
E P Zorrilla, and
C J Heyser, and
J Rivier, and
W Vale, and
E Merlo-Pich, and
G F Koob
October 2004,
Physiology & behavior,
M G Spina, and
A M Basso, and
E P Zorrilla, and
C J Heyser, and
J Rivier, and
W Vale, and
E Merlo-Pich, and
G F Koob
April 1990,
Brain research,
M G Spina, and
A M Basso, and
E P Zorrilla, and
C J Heyser, and
J Rivier, and
W Vale, and
E Merlo-Pich, and
G F Koob
February 2011,
PloS one,
M G Spina, and
A M Basso, and
E P Zorrilla, and
C J Heyser, and
J Rivier, and
W Vale, and
E Merlo-Pich, and
G F Koob
October 2007,
Biological & pharmaceutical bulletin,
M G Spina, and
A M Basso, and
E P Zorrilla, and
C J Heyser, and
J Rivier, and
W Vale, and
E Merlo-Pich, and
G F Koob
January 1997,
Brain research,
M G Spina, and
A M Basso, and
E P Zorrilla, and
C J Heyser, and
J Rivier, and
W Vale, and
E Merlo-Pich, and
G F Koob
February 1997,
The Journal of pharmacology and experimental therapeutics,
M G Spina, and
A M Basso, and
E P Zorrilla, and
C J Heyser, and
J Rivier, and
W Vale, and
E Merlo-Pich, and
G F Koob
August 1999,
The Journal of pharmacology and experimental therapeutics,
M G Spina, and
A M Basso, and
E P Zorrilla, and
C J Heyser, and
J Rivier, and
W Vale, and
E Merlo-Pich, and
G F Koob
November 2022,
Peptides,
M G Spina, and
A M Basso, and
E P Zorrilla, and
C J Heyser, and
J Rivier, and
W Vale, and
E Merlo-Pich, and
G F Koob
June 2009,
Hormones and behavior,
M G Spina, and
A M Basso, and
E P Zorrilla, and
C J Heyser, and
J Rivier, and
W Vale, and
E Merlo-Pich, and
G F Koob
August 1978,
Neuropharmacology,
